Javascript must be enabled to continue!
Amantadine Modulates Action‐Specific Neural Ensembles in Hypokinetic and Hyperkinetic Conditions
View through CrossRef
Abstract
Background
In the classical model of basal ganglia circuitry, striatal spiny projection neurons of the direct and indirect pathways (dSPNs, iSPNs) promote and suppress movement, respectively, and exhibit unbalanced activity levels during hypokinetic or hyperkinetic conditions. Most therapies for these conditions are thought to work by rebalancing the relative activity of dSPNs and iSPNs toward normal levels. However, the mechanism of amantadine, which uniquely improves both hypokinetic and hyperkinetic conditions, is poorly understood.
Objective
Our aim was to determine whether amantadine restores motor function by normalizing the balance of dSPN and iSPN activity or through a distinct mechanism.
Methods
We used dual‐color two‐photon Ca
2+
imaging in the 6‐hydroxydopamine (6‐OHDA) mouse model of Parkinson's disease to concurrently monitor dSPN and iSPN dynamics across healthy, hypokinetic (parkinsonian), and hyperkinetic (dyskinetic) conditions.
Results
We evaluated both dSPN/iSPN activity balance and action‐specific neural ensemble activity in the dorsolateral striatum. In hypokinetic conditions, levodopa rescued the dSPN/iSPN imbalance but failed to restore the disrupted activity of the locomotion‐specific ensemble. Conversely, amantadine improved locomotion‐specific ensemble activity without normalizing the dSPN/iSPN imbalance. In hyperkinetic conditions, forelimb dyskinesias were characterized by neural activity patterns distinct from those encoding locomotion. Amantadine selectively suppressed the resting activity of forelimb dyskinesia ensembles without affecting locomotion‐coding ensembles or restoring pathway balance.
Conclusions
Levodopa and amantadine may act through distinct mechanisms, with levodopa normalizing pathway balance and amantadine modulating action‐specific neural ensembles. These findings support the importance of action‐coding disruptions during hypokinetic and hyperkinetic conditions and suggest that correcting them can restore motor function. © 2026 International Parkinson and Movement Disorder Society.
Title: Amantadine Modulates Action‐Specific Neural Ensembles in Hypokinetic and Hyperkinetic Conditions
Description:
Abstract
Background
In the classical model of basal ganglia circuitry, striatal spiny projection neurons of the direct and indirect pathways (dSPNs, iSPNs) promote and suppress movement, respectively, and exhibit unbalanced activity levels during hypokinetic or hyperkinetic conditions.
Most therapies for these conditions are thought to work by rebalancing the relative activity of dSPNs and iSPNs toward normal levels.
However, the mechanism of amantadine, which uniquely improves both hypokinetic and hyperkinetic conditions, is poorly understood.
Objective
Our aim was to determine whether amantadine restores motor function by normalizing the balance of dSPN and iSPN activity or through a distinct mechanism.
Methods
We used dual‐color two‐photon Ca
2+
imaging in the 6‐hydroxydopamine (6‐OHDA) mouse model of Parkinson's disease to concurrently monitor dSPN and iSPN dynamics across healthy, hypokinetic (parkinsonian), and hyperkinetic (dyskinetic) conditions.
Results
We evaluated both dSPN/iSPN activity balance and action‐specific neural ensemble activity in the dorsolateral striatum.
In hypokinetic conditions, levodopa rescued the dSPN/iSPN imbalance but failed to restore the disrupted activity of the locomotion‐specific ensemble.
Conversely, amantadine improved locomotion‐specific ensemble activity without normalizing the dSPN/iSPN imbalance.
In hyperkinetic conditions, forelimb dyskinesias were characterized by neural activity patterns distinct from those encoding locomotion.
Amantadine selectively suppressed the resting activity of forelimb dyskinesia ensembles without affecting locomotion‐coding ensembles or restoring pathway balance.
Conclusions
Levodopa and amantadine may act through distinct mechanisms, with levodopa normalizing pathway balance and amantadine modulating action‐specific neural ensembles.
These findings support the importance of action‐coding disruptions during hypokinetic and hyperkinetic conditions and suggest that correcting them can restore motor function.
© 2026 International Parkinson and Movement Disorder Society.
Related Results
Amantadine modulates action-specific neural ensembles in hypokinetic and hyperkinetic conditions
Amantadine modulates action-specific neural ensembles in hypokinetic and hyperkinetic conditions
ABSTRACT
Background
In the classical model of basal ganglia circuitry, striatal spiny projection neurons of the direct and indi...
Movement Disorders in Toxoplasmosis: A Systematic Review
Movement Disorders in Toxoplasmosis: A Systematic Review
Background: Movement disorders are an uncommon but important manifestation of central nervous system toxoplasmosis. Their phenotypes, lesion patterns, and outcomes have not been sy...
Corneal Evaluation in Patients With Parkinsonism on Long-Term Amantadine Therapy
Corneal Evaluation in Patients With Parkinsonism on Long-Term Amantadine Therapy
Purpose:
To evaluate the progression of corneal endothelial changes in patients with Parkinson disease (PD) on long-term oral amantadine therapy.
...
NMDA receptor antagonist amantadine in treatment of neuropathic orofacial pain
NMDA receptor antagonist amantadine in treatment of neuropathic orofacial pain
Neuropathic orofacial pain caused by trauma to the distal branches of the trigeminal nerve is most often an iatrogenic complication in the practice of dentists, maxillofacial surge...
Ensembles of ensembles of ensembles: On using low-dimensional nonlinear systems to design climate prediction experiments
Ensembles of ensembles of ensembles: On using low-dimensional nonlinear systems to design climate prediction experiments
<p>The challenges of climate prediction are varied and complex. On the one hand they include conceptual and mathematical questions relating to the consequences of mod...
Amantadine-Induced Hypoglycemia in a Patient Without a History of Diabetes Mellitus
Amantadine-Induced Hypoglycemia in a Patient Without a History of Diabetes Mellitus
Abstract
Introduction: Hypoglycemia, a state of low blood glucose, has multiple etiologies with the most common being drug-induced hypoglycemia particularly in in...
COMPARATIVE ANTI-INFLUENZA POTENTIAL OF MORINGA OLEIFERA LEAVES AND AMANTADINE INVITRO
COMPARATIVE ANTI-INFLUENZA POTENTIAL OF MORINGA OLEIFERA LEAVES AND AMANTADINE INVITRO
Introduction: Influenza is an extremely communicable respirational disease with widespread morbidity and mortality. Amantadine is a standard drug used against influenza virus and b...
Efficacy of ademol in experimental cranial injury on the effect of oxidative stress
Efficacy of ademol in experimental cranial injury on the effect of oxidative stress
Objective. To evaluate the effectiveness and safety of ademol for oxidative stress in the brain of rats with traumatic brain injury (TBI).
Materials and methods. In 260 male-...

